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Summary
Bone morphogenetic proteins (BMPs) regulate multi-
ple biological processes, including cellular prolifera-
tion, adhesion, differentiation, and early development.
In Xenopus development, inhibition of the BMP path-
way is essential for neural induction. Here, we report
that dullard, a gene involved in neural development,
functions as a negative regulator of BMP signaling.
We show that Dullard promotes the ubiquitin-medi-
ated proteosomal degradation of BMP receptors
(BMPRs). Dullard preferentially complexes with the
BMP type II receptor (BMPRII) and partially colocalizes
*Correspondence: asashi@bio.c.u-tokyo.ac.jp
7 These authors contributed equally to this work.with the caveolin-1-positive compartment, suggesting
that Dullard promotes BMPR degradation via the lipid
raft-caveolar pathway. Dullard also associates with
BMP type I receptors and represses the BMP-depen-
dent phosphorylation of the BMP type I receptor. The
phosphatase activity of Dullard is essential for the
degradation of BMP receptors and neural induction
in Xenopus. Together, these observations suggest
that Dullard is an essential inhibitor of BMP receptor
activation during Xenopus neuralization.
Introduction
Bone morphogenetic proteins (BMPs) are multifunc-
tional growth factors that belong to the transforming
growth factor-b (TGF-b) superfamily. Studies from
transgenic and knockout mice revealed that BMP sig-
naling is critical for vertebrate development (Zhao,
2003). Disruption of BMP signaling has been impli-
cated in inherited cancers and various other diseases
(Waite and Eng, 2003). Given these implications for
human disease processes, it would be valuable to elu-
cidate the mechanisms by which BMP signaling is
regulated.
BMPs bind type I and type II cell-surface serine/thre-
onine kinase receptors (BMPRI and BMPRII), thereby
activating BMPRI, which, in turn, phosphorylates the
C-terminal motif of BMP-Smads (Smad1, Smad5, and
Smad8). These phosphorylated BMP-Smads then form
a complex with Smad4 to activate the expression of
BMP target genes in the nucleus. This pathway is regu-
lated by multiple factors, including BMP antagonists, re-
ceptor-binding proteins, inhibitory Smads (Smad6 and
Smad7), transcription factors, ubiquitin ligases, Smad
phosphatases, and crosstalk with other signaling path-
ways (Chen et al., 2006; Derynck and Zhang, 2003; Mas-
sague and Chen, 2000).
In Xenopus, BMP signaling induces the ventral meso-
derm and epidermis and negatively regulates neurogen-
esis (Reversade and De Robertis, 2005; Dosch et al.,
1997; Wilson et al., 1997; Northrop et al., 1995; Schmidt
et al., 1995). Secreted factors such as follistatin, noggin,
and chordin are expressed in the organizer region of
Xenopus embryos and induce early neural genes by di-
rectly neutralizing BMPs (Khokha et al., 2005; Ray and
Wharton, 2001; Sasai, 2001).
We have shown previously that the dullard gene is es-
sential for neural development in Xenopus (Satow et al.,
2002). Here, we report that Dullard functions as an inhib-
itory factor for BMP signaling. Dullard specifically in-
hibits BMP signaling by promoting the ubiquitin-medi-
ated proteosomal degradation of BMP receptors.
Dullard functions as a phosphatase, and this activity is
essential for BMP signal inhibition and the degradation
of BMPRII. Furthermore, we provide evidence that Dull-
ard also inhibits BMP signaling by dephosphorylating
BMPRI. Our results suggest that Dullard plays a crucial
role for neural induction during Xenopus embryogenesis
by negatively regulating BMP signaling.
Developmental Cell
764Figure 1. Dullard Is a Phosphatase that Suppresses BMP Signaling in Xenopus Ectoderm
(A) The increased expression of XSIP1 and Zic3 in dullard mRNA-injected animal caps. Uninjected or dullard mRNA (50, 100, or 300 pg)-injected
animal caps were harvested at stage 13 for RNA isolation and RT-PCR.
(B) dullard suppressed the BMP4-induced expression of Xvent-1, msx1, and Xbra in a dose-dependent manner. BMP4 and dullard mRNAs were
injected as indicated. Animal caps were harvested at stage 10+, and the expression of Xvent-1, msx1, and Xbra was analyzed by RT-PCR.
(C)Xbra induced byXnr5was not suppressed by coinjection with dullard.Xnr5 (5 pg) and dullard (300 pg)-injected animal caps were harvested at
stage 10+, and the expression of Xbra was analyzed by RT-PCR.
(D) Phosphatase activity of immunoprecipitated Dullard in vitro. Myc-tagged Dullard (wild-type) and the phosphatase-inactive mutants, D67E
and D69E, were immunoprecipitated from embryos injected with the respective mRNAs. Control experiments were performed with uninjected
embryos. Phosphatase activity was determined by measuring the amount of p-nitrophenol converted from the substrate, p-nitrophenol
phosphate.
(E) Control blot of myc-Dullard proteins immunoprecipitated in (D).
(F) The expression of Xbra, Xvent-1, and msx1 induced by BMP4 was suppressed by coinjection with dullard, but not by D67E or D69E. Animal
cap assays were performed. BMP4 (300 pg), dullard (300 pg), D67E (1.5 ng), or D69E (1.5 ng) was injected as indicated. Animal caps were
harvested at stage 10+, and RT-PCR was performed.Results
Dullard Neuralizes Xenopus Explants
by Antagonizing BMP Signaling
We showed previously that translational inhibition of
dullard blocks normal neural development in Xenopus
(Satow et al., 2002). To elucidate the mechanism under-
lying the contribution of Dullard to neural development,
animal cap assays were performed and assessed the ef-
fect of dullard on the expression of early neural genes.
As shown in Figure 1A, injection of dullard mRNA into
animal caps upregulated the early neural genes Zic3
and XSIP1 in a dose-dependent manner. Since inactiva-
tion of the BMP pathway in ectodermal cells is essential
for neural induction, we hypothesized that Dullard may
induce neural development by antagonizing BMP sig-
naling. To test this possibility, we coinjected dullard
and BMP4 mRNA into animal caps and analyzed theexpression of the BMP target genes Xvent-1, Msx-1,
and Xbra. As shown in Figure 1B, the expression of
these genes was significantly suppressed by Dullard in
a dose-dependent manner. We also examined the effect
of dullard on activin-like signaling in animal caps and re-
vealed that Xbra expression, induced by the overex-
pression of Xnr5 (Takahashi et al., 2000), was unaffected
by Dullard in coinjection experiments (Figure 1C). These
results indicate that Dullard specifically antagonizes
BMP signaling, but not activin-like signaling.
The Phosphatase Activity of Dullard Is Responsible
for Its BMP-Repressing Ability
A BLAST domain search identified the catalytic phos-
phatase motifjjjDXDX(T/V)jj (j: a hydrophobic amino
acid residue) in Dullard. This motif is found in several
serine/threonine phosphatases, including FCP1, a RNA
polymerase II CTD phosphatase (Palancade et al.,
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765Figure 2. Dullard Promotes Degradation of BMP Receptors
(A) BMP4-induced phosphorylation of Smad1/5/8 was suppressed by coinjection with dullard, but not D67E or D69E. Animal caps injected with
BMP4 (300 pg), dullard (300 pg), D67E (300 pg), or D69E (300 pg) were dissected at stages 8.5/9, incubated until stage 10, and then analyzed by
immunoblotting.
(B) Dullard inhibited recombinant BMP4-induced phosphorylation of Smad1/5/8. Uninjected or dullard (300 pg)-injected animal caps were dis-
sected at stage 9, incubated with rhBMP4 (50 ng/ml) for 2 hr, and then harvested for immunoblotting.
(C and D) Dullard did not inhibit (C) activin-induced phosphorylation of Smad2 or (D) bFGF-induced phosphorylation of MAPK. The animal cap
assay was performed as described in (B), but the caps were treated with activin (50 ng/ml) or with bFGF (150 ng/ml) for 2 hr.
(E) Dullard failed to suppress the phosphorylation of Smad1/5/8 induced by constitutively active ALK3. Constitutively active ALK3 (caALK3-HA)
(300 pg), dullard (300 pg), or Smad7 (300 pg) was injected, and immunoblotting of phospho-Smad1/5/8 was performed as described in (B).
(F) The protein levels of BMP receptors were reduced by coexpression of Dullard. ALK3-HA (500 pg), BMPRII-HA (BRII-HA) (300 pg), and dullard
(300 pg) were injected as indicated, and the receptors were detected with HA antibody.
(G) Dullard downregulated the protein level of BMPRII, but not ActRII. ActRII-HA (300 pg), BMPRII-HA (300 pg), or dullard (300 pg) was expressed
as indicated.
(H) The protein level of BMPRII-HA was reduced by coexpression with Dullard, but not with D67E or D69E. BMPRII-HA (300 pg), myc-Dullard
(300 pg), myc-D67E (300 pg), and myc-D69E mRNA (300 pg) were injected as indicated.2001; Cho et al., 1999; Archambault et al., 1997, 1998).
In order to test whether Dullard functions as a phospha-
tase, we made mutants of dullard, D67E and D69E, in
which the first or second essential aspartate residue,
respectively, within the catalytic motif was changed to
a glutamate, as described previously in FCP1 (Haus-
mann and Shuman, 2002; Palancade et al., 2001).
In vitro phosphatase assays (Hausmann and Shuman,
2002) with immunoprecipitated myc-tagged Dullard us-
ing p-nitrophenyl phosphate as a substrate revealed
that Dullard has significant phosphatase activity. In con-
trast, the D67E and D69E mutants retained only weak
phosphatase activity compared to the wild-type control
(Figures 1D and 1E). Animal cap assays also revealed
that the phosphatase-inactive mutants had no BMP-
antagonizing activity when coexpressed with BMP4
(Figure 1F, lanes 6 and 7). Furthermore, coinjection of
mutant mRNA with dullard reversed the expression of
BMP-responsive genes that were suppressed by dullard
alone (Figure 1F, lanes 4 and 5), indicating that D67E and
D69E function in a dominant-negative manner. These
results clearly show that the phosphatase activity of
Dullard is responsible for its inhibitory effects on BMP
signaling.Dullard Blocks BMP Signaling by Promoting
Degradation of BMP Receptors
To elucidate how Dullard represses BMP signaling, we
examined the effect of dullard on BMP-dependent
phosphorylation of Smad proteins with animal cap as-
says. Phosphorylation of Smad1/5/8 induced by injec-
tion of BMP4 mRNA was reduced by coexpression
with dullard. By comparison, the phosphatase-inactive
mutants, D67E and D69E, did not suppress the BMP-
dependent phosphorylation of Smad1/5/8 (Figure 2A).
Dullard also inhibited the phosphorylation of Smad1/5/8
induced by treatment with the recombinant human
BMP4 protein (rhBMP4) (Figure 2B). Dullard specifically
suppressed the BMP-dependent activation of intra-
cellular signaling, as evidenced by Dullard failing to
suppress both the activin-induced phosphorylation of
Smad2 (Figure 2C) and the bFGF-induced phosphoryla-
tion of MAPK (Figure 2D).
To understand mechanistically how Dullard inhibits
BMP signaling, we next examined whether Dullard af-
fects complex formation between the ligand and recep-
tors or between type I and type II receptors. Dullard in-
hibited neither the binding between BMPRI, ALK3, and
BMP4 (Figure S1; see the Supplemental Data available
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ation of ALK3 and BMPRII (Figure S2). No binding was
observed in control immunoprecipitation experiments
for the binding of ALK4 and BMP4 (Figure S3), confirm-
ing the specific nature of the interaction between ALK3
and BMP4.
Dullard also blocked the phosphorylation of
Smad1/5/8 induced by coinjection of BMPRII and
ALK3 (Figure S4). Interestingly, when constitutively
active ALK3 (caALK3) was expressed to activate BMP
signaling (Wieser et al., 1995), Dullard failed to suppress
the phosphorylation of Smad1/5/8, although an intra-
cellular inhibitor of TGF-b family signaling, Smad7, com-
pletely inhibited the BMP-dependent phosphorylation
of these Smad proteins (Figure 2E). These results sug-
gested that Dullard inhibits the activation of BMPRIs,
but not the activation of downstream signaling path-
ways. In these experiments, we noticed that the BMPR
protein levels were reduced when coexpressed with
Dullard (Figure S2), raising the possibility that Dullard
downregulates BMPRII protein levels. This possibility
was tested by Dullard overexpression, which caused
a significant decrease in BMPRII (Figures 2F–2H), but
not ALK3, protein levels (Figure 2F, lane 3). When ALK3
was coexpressed with BMPRII in the presence of Dull-
ard, the protein levels of ALK3 decreased (Figure 2F,
lane 5). These effects were BMPR specific, as Dullard
expression did not change the activin-receptor level
(Figure 2G). This result was confirmed by the finding
that the phosphatase-inactive mutants, D67E and
D69E, failed to decrease the protein level of BMPRII
(Figure 2H). Together, these observations suggested
that Dullard promotes degradation of BMPRs in a
phosphatase activity-dependent manner.
Dullard Promotes Ubiquitin-Dependent Proteasomal
Degradation of BMPRII and Dephosphorylation
of ALK3
Dullard also inhibits BMP signaling in mammalian cells.
A BMP-responsive mouse cell line, C2C12, was trans-
fected with Flag-Dullard, treated with rhBMP4, and
then immunostained with an anti-phospho-Smad1/5/8
antibody. While nontransfected cells showed distinct
BMP-induced nuclear staining of phosphorylated
Smads (data not shown; Figure 3B), cells expressing
wild-type Dullard showed significantly weaker nuclear
staining compared to surrounding nonexpressing cells
(Figures 3A and 3B). This reduction in nuclear phospho-
Smads was not seen, however, with the D67E mutant
(Figures 3A and 3B). Western blotting analysis confirmed
the Dullard-induced decrease in phosphorylation of
BMP-Smads (Figure 3C). The overexpression of Dullard
in mammalian cells further confirmed that Dullard re-
duced the protein level of BMPRII in a dose-dependent
manner (Figure 3D). Interestingly, the degradation of
BMPRII was reversed by treatment with MG132, a pro-
teasomal inhibitor (Figure 3E). Dullard was also stabi-
lized as well with MG132, suggesting that Dullard itself
is degraded along with BMPRII (also see Figures 5B
and 5C). Overexpression of Dullard markedly enhanced
the ubiquitination of BMPRII (Figure 3F). The phospha-
tase-inactive mutant D67E showed reduced ubiquitina-
tion of the receptor, suggesting that the phosphatase ac-
tivity of Dullard is important for this process. Together,these results indicate that Dullard promotes the ubiqui-
tin-dependent proteasomal degradation of BMPRII.
We next analyzed the interaction between Dullard and
the receptors by coimmunoprecipitation to elucidate the
specificity of Dullard for receptor degradation. The assay
was performed with cells harvested 24 hr posttransfec-
tion, as overexpression of Dullard significantly degrades
BMP receptors in extended culture periods (data not
shown), which causes uneven protein levels of the re-
ceptors in lysate. As shown in Figure 3G, BMPRII was
coimmunoprecipitated with Dullard, but very low levels
of ActRIIA were detected under the same conditions.
These results indicate that Dullard specifically forms
a complex with BMPRII, but not with the activin receptor.
Similar experiments were performed to test the associa-
tion of Dullard with the BMPRIs. As shown in Figure 3H,
both BMPRII and ALK3 were coimmunoprecipitated
with Dullard, although Dullard interacted more robustly
with BMPRII than with ALK3. Testing of other BMPRIs,
ALK2 and ALK6, revealed that these two receptors also
interacted with Dullard (data not shown). Moreover, in-
teraction between BMPRIs and Dullard was not depen-
dent on the receptor kinase activity (data not shown).
Furthermore, the interaction between Dullard and
BMPRII was not dependent on the phosphatase activity
of Dullard, as the phosphatase-inactive mutant Dullard
still formed a complex with BMPRII (Figure 3I). These re-
sults indicate that Dullard preferentially forms a complex
with BMPRII and promotes ubiquitination and degrada-
tion of BMPRs. Since Dullard is a serine/threonine phos-
phatase and binds to BMPRIs, it is possible that Dullard
may also inhibit BMP signaling by dephosphorylating
BMPRIs. To test this, Dullard was overexpressed, and
the phosphorylation of ALK3 was examined. As ex-
pected, the BMP-dependent phosphorylation of ALK3
was significantly inhibited by coexpression with Dullard
(Figures 3J–3L). To test whether Dullard directly dephos-
phorylates ALK3, we performed in vitro phosphatase
assays by mixing immunoprecipitated Dullard and
phosphorylated ALK3-HA immunoprecipitated from
BMP-treated C2C12 cells. Wild-type, but not the
phosphatase-inactive Dullard, facilitated the dephos-
phorylation of ALK3-HA in vitro (Figure 3M). These re-
sults demonstrated that, in addition to its role in BMPRII
degradation, Dullard also inactivates BMP signaling by
dephosphorylating BMPRIs.
Dullard Segregates BMPRII to Caveolae
Immunofluorescence analysis revealed a perinuclear,
punctate expression of ectopically expressed Flag-Dull-
ard in mammalian cells (Figure 4A). Dullard was local-
ized in the cytoplasm, but not in the nucleus. By compar-
ison, BMPRII-HA was localized diffusely at the cell
surface. Coexpression of Flag-Dullard and BMPRII-HA
markedly decreased the expression of BMPRII, with re-
sidual receptor colocalizing with Dullard in perinuclear
puncta (Figure 4A). We further analyzed the dotted local-
ization of transiently expressed Flag-Dullard in mamma-
lian cells. As shown in Figure 4B, Dullard localized inde-
pendently of an early endosome marker, EEA1, but
partially colocalized with caveolin-1, a marker of the lipid
raft-dependent caveolar pathway. These results sug-
gested that Dullard expression might also segregate
BMPRII to caveolin-rich membranes. To test this theory,
Dullard Inhibits BMP Receptor Activation
767Figure 3. Dullard Promotes Ubiquitin-Dependent Proteasomal Degradation of BMPRII and Dephosphorylation of ALK3
(A) Dullard inhibited the nuclear staining of phospho-Smad1/5/8 in mammalian cells. C2C12 cells were transfected with Flag-Dullard, serum
depleted for 24 hr, and then treated with rhBMP4 (100 ng/ml) for 30 min before immunostaining with phospho-Smad1/5/8 (green) and Flag
(red) antibodies.
(B) Quantitation of phospho-Smad1/5/8-positive cells in (A).
(C) Dullard inhibited BMP-dependent phosphorylation of Smad1/5/8 in mammalian cells. A BMP-responsive human cell line, HepG2, was treated
with rhBMP4 (50 ng/ml) for 30 min, and the lysate was immunoblotted with anti-phospho-Smad1/5/8 antibody.
(D) Dullard promoted the degradation of BMPRII in a dose-dependent manner. COS7 cells transfected with BMPRII-HA and a different dose of
either wild-type or mutant Dullard were lysed 48 hr posttransfection, and BMPRII levels were detected by immunoblotting.
(E) Dullard promoted the degradation of BMPRII via the proteasomal pathway. BMPRII-HA and Flag-Dullard were used to transfect 293T cells as
indicated. At 15 hr posttransfection, cells were treated with 15 mM MG132 for 15 hr, and the total lysate was prepared for immunoblotting. The
amount of BMPRII DNA used in this experiment was the same for each lane. An immunoblot of a-tubulin is the loading control.
(F) Dullard promoted the ubiquitination of BMPRII-HA. Flag-ubiquitin, myc-Dullard, and BMPRII-HA were transfected as indicated. At 34 hr post-
transfection, cells were treated with 15 mM MG132 for 8 hr, and immunoprecipitation was performed with Flag antibody. The ubiquitinated
BMPRII was detected with HA antibody. The asterisk indicates nonspecific bands.
(G and H) Dullard preferentially formed a complex with BMPRII. Coimmunoprecipitation assays were performed with Flag antibody, and asso-
ciated receptors were blotted with HA antibody.
(I) Dullard associated with BMPRII in a phosphatase activity-independent manner.
(J–L) Dullard inhibited BMP-dependent phosphorylation of the type I receptor. C2C12 cells were transfected, depleted of serum for 12 hr, and
then treated with 100 ng/ml rhBMP4 for 15 min. (J) Phosphoproteins were purified on a PhosphoProtein Purification Column, and phosphorylated
ALK3-HA was detected with HA antibody. (K) C2C12 cells were labeled with 32P-phosphate before rhBMP4 treatment, and phosphorylation of
immunopurified ALK3-HA with HA antibody was analyzed with a phosphoimager. (L) The phosphorylated ALK3 bands in (K) were quantitated.
(M) In vitro dephosphorylation of phosphorylated ALK3-HA by Dullard. Phosphorylated ALK3-HA beads prepared as in (K) were incubated at
30C for 60 min with immunoprecipitated Flag-Dullard beads purified from transiently transfected COS7 cells. Dephosphorylation of ALK3-
HA was analyzed as in (K) and (L).cells were cotransfected with Flag-Dullard and BMPRII-
HA, and the localization of BMPRII was examined.
Expressed alone, BMPRII mainly localized at the cell
surface (Figure 4C, Mock) and did not show apparent
colocalization with caveolin-1, whereas in the presence
of Dullard coexpression, BMPRII partially colocalized
with caveolin-1, but not EEA1 (Figure 4C). These resultssuggest that Dullard recruited the receptor to the
caveolin-dependent endocytic pathway to promote
degradation of the receptor. In fact, the liganded endog-
enous BMP receptors were localized to both raft and
non-raft compartments, as indicated by the sucrose-
density fractionation of C2C12 cells affinity labeled with
125I-BMP4 (Figure 5A). Ectopically expressed Dullard
Developmental Cell
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(A) Subcellular localization of Dullard and BMPRII. Cells were transfected with Flag-Dullard (top lane), BMPRII-HA (middle lane), and both Flag-
Dullard and BMPRII-HA (bottom lane). Immunostaining was performed with anti-Flag (left column) or anti-HA (middle column) antibodies.
(B) Dullard partially colocalized with caveolin-1, but not EEA1. HeLa cells were transfected with Flag-Dullard and immunostained with anti-Flag
(left column) and either anti-EEA1 or anti-caveolin-1 (middle column) antibodies. Cells in the white square in the right bottom panel were further
analyzed by confocal microscopy (enlarged).
(C) Dullard recruited BMPRII to the caveolin-1-positive compartment. HeLa cells transfected with both Flag-Dullard and BMPRII-HA were sub-
jected to immunofluorescence. Cells were stained with anti-HA (top), anti-EEA1, or anti-caveolin-1 (middle) antibodies.
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(A) Liganded BMP receptors localized in both raft and non-raft compartments. C2C12 cells crosslinked with 125I-BMP4 were lysed and fraction-
ated by sucrose gradient subcellular fractionation. The bottom panel shows an immunoblot with Flag antibody of independent fractionation of
C2C12 cells transfected with Flag-Dullard.
(B) Nystatin inhibited BMPRII degradation induced by Dullard. COS7 cells transfected with indicated plasmids were treated with Nystatin
(25 mg/ml) or cholesterol (25 mg/ml) for 14 hr.
(C) KCl deprivation enhanced the degradation of BMPRII by Dullard. COS7 cells transfected with indicated plasmids. The cells were cultured with
or without 10 mM KCl for 5 hr 48 hr posttransfection.
(D) The dominant-negative Eps15 mutant did not inhibit BMPRII degradation by Dullard.
(E and F) Dullard-dependent inhibition of BMP signaling occurred via a caveolin-dependent pathway. Luciferase assays with a BMP-Smad
reporter were performed with C2C12 cells as described in Experimental Procedures. The averaged data for normalized reporter activity are
shown with standard errors derived from duplicate transfections.also localized to raft compartments (Figure 5A, bottom
panel). To further confirm this, inhibitors of the caveolar
and clathrin endocytic pathways were included in our
experimental system. Treatment with Nystatin, a choles-
terol-depleting drug, known to abolish caveolae struc-
ture and its function, rescued the Dullard-induced deg-
radation of BMPRII (Figure 5B), thereby implicating
cholesterol-rich lipid raft compartments in the degrada-
tion. In contrast, KCl deprivation, which inhibits clathrin-
dependent endocytosis, but not the caveolar pathway,
rather promoted the degradation of BMPRII (Figure 5C),
further supporting a role for a nonclathrin endocytic
component. Furthermore, dominant-negative Eps15
(DIII), which also inhibits clathrin-dependent internaliza-
tion by binding to the AP-2 adaptor (Benmerah et al.,
1998) (but not the inactive variant, DIIID2), failed to
inhibit the Dullard-dependent BMPRII degradation (Fig-
ure 5D). The effects of these inhibitors on the degrada-
tion of BMPRII were also analyzed by luciferase assays.
While treatment with Nystatin antagonized the Dullard-
dependent inhibition of BMP signaling (Figure 5E), an
Eps15 mutant, DIII, failed to rescue the inhibition by Dull-
ard (Figure 5F). These data therefore support our model
that Dullard promotes the degradation of BMPRII via
a lipid raft/caveolin-dependent pathway.Functional Knockdown of dullard Upregulates BMP
Target Genes in Developing Embryos
To determine whether endogenous dullard also nega-
tively regulates BMP signaling, animal cap assays were
performed with D67E, D69E, and an antisense morpho-
lino oligonucleotide for dullard (Dullard-Mo). D67E and
D69E were shown in earlier experiments to act in a dom-
inant-negative manner with regard to BMP signaling.
Dullard-Mo was first reported previously (Satow et al.,
2002), and as shown in Figure S5, this reagent efficiency
blocked the translation. Figure 6A shows that injection
of D67E or Dullard-Mo upregulated the phosphorylation
of Smad1/5/8. RT-PCR analysis revealed that D67E,
D69E, and Dullard-Mo also upregulated the expression
of Msx1, a BMP target gene, and that this induced ex-
pression was suppressed by coinjection with domi-
nant-negative BMPR (tBR) (Suzuki et al., 1994) (Fig-
ure 6B). Dullard-Mo also induced the expression of
other BMP target genes, Bambi and Xvent-1, while
control-Mo did not (Figure 6C). A second morpholino
oligonucleotide for dullard (Dullard-Mo2), targeting the
50 UTR sequence of dullard, also quite efficiently sup-
pressed the expression of Dullard (Figure S5) and
induced the expression of Bambi (Onichtchouk et al.,
1999) and Xvent-1 (Figure 6C). Luciferase assays with
Developmental Cell
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BMP Signaling
(A) Inhibition of dullard upregulated the phos-
phorylation of Smad1/5/8. Animal cap assays
were done with Dullard-Mo (40 ng) or D67E
(1.5 ng) mRNA-injected embryos. The relative
intensity of the phospho-Smad1/5/8 immu-
noblot compared to actin was also mea-
sured. The averaged data for immunoblot
are shown with standard errors derived from
duplicate experiments.
(B) Inhibition of dullard induced the expres-
sion of Msx1. Dullard-Mo (40 ng), mRNAs of
D67E (1.5 ng) and D69E (1.5 ng), or domi-
nant-negative BMP receptor (tBR) (750 pg)
was injected, and animal cap assays were
performed to analyze the expression ofMsx1.
(C) Knockdown of dullard upregulated the ex-
pression of Bambi and Xvent-1. The embryos
injected with Dullard-Mo (40 ng), Dullard-Mo2
(20 ng), or control-Mo (40 ng) were subjected
to animal cap assays, and the expression of
Bambi and Xvent-1 was measured.
(D) Luciferase assays were performed with
the promoter of Xvent2. XVent2-Luc (50 pg),
BMP4 (100 pg), Dullard-Mo (40 ng), and
5mis-Mo (40 ng) were injected into the animal
pole region, and animal caps were dissected
for luciferase activity. For an internal control,
pRL-TK (50 pg) (Promega) was used. In each
experiment, pGL-Basic (50 pg) (Promega)
was also used, and the relative intensity to
pGL-Basic is shown. The averaged data for
normalized reporter activity are shown with
standard errors derived from duplicate trans-
fections.the Xvent2 promoter (Candia et al., 1997) revealed that
BMP4-upregulated reporter activity was enhanced by
coinjection with Dullard-Mo, but not by 5mis-Mo (Fig-
ure 6D). These results indicate that endogenous Dullard
also inhibits BMP signaling and represses the expres-
sion of BMP response genes.
Dullard Contributes to the Expression of Early
Neural Genes
We previously showed that translational inhibition of
dullard blocked neural tube formation and inhibited
head development (Satow et al., 2002). Here, we show
that microinjection of Dullard-Mo or Dullard-Mo2, but
not control-Mo or 5mis-Mo, significantly reduced the ex-
pression of the early neural marker genes SoxD, XSIP1,
and Zic3, which are upregulated upon BMP inhibition
(Figure 7). Furthermore, D67E and D69E exerted similar
effects to Dullard-Mo and Dullard-Mo2 on the expres-
sion of these early neural markers. These results indi-
cate that endogenous Dullard contributes to the expres-
sion of early neural genes by negatively regulating BMP
signaling during development.
Discussion
The present study showed that Dullard functions as
a regulator of BMP signaling that promotes ubiquitin-
dependent proteasomal degradation of BMPRII and
dephosphorylates BMPRIs. Dullard specifically inhibits
BMP signaling and does not prevent other signaling
pathways, such as activin/nodal or FGF signaling. Asshown by binding studies, inhibition of BMP signaling
is due to the specific targeting of BMPRs by Dullard.
Several proteins have been reported to promote the
degradation of BMP-signaling components (Miyazono
et al., 2005). To our knowledge, Dullard is the first protein
shown to specifically promote the degradation of type II
receptors of the TGF-b superfamily. Although we ob-
served weaker interaction of Dullard with type I recep-
tors, we failed to detect efficient degradation of ALK3
by Dullard, and expression of ALK3 was significantly
downregulated only in the presence of BMPRII coex-
pression. These results therefore indicate that Dullard
preferentially recognizes BMPRII and promotes degra-
dation of BMPRII and of the complex formed with this
receptor.
It has been shown that lipid raft/caveolin-dependent
endocytosis is required for rapid TGF-b receptor turn-
over of the Smad7-Smurf2-bound receptor (Di Guglielmo
et al., 2003). Recent studies suggest that lipid raft-
enriched membrane domains might represent a general
membrane location for ubiquitin ligases and related mol-
ecules (Le Roy and Wrana, 2005). The present study
localized Dullard to cytoplasmic puncta, partially over-
lapping with caveolin, but not with the early endosome
marker EEA1. Moreover, the observation that transient
coexpression of Dullard promoted the ubiquitination
of BMPRII, and that the proteasome inhibitor MG132
blocked its degradation, suggested that Dullard pro-
motes ubiquitin-mediated proteasomal degradation of
BMPRII byusingacombination of as yetunidentified ubiq-
uitin ligases that reside in the lipid raft/caveolin fraction.
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mRNA of D67E (1.5 ng) or D69E (1.5 ng), control-Mo (40 ng), Dullard-Mo (40 ng), Dullard-Mo2 (20 ng), or 5-mis Mo (40 ng) was microinjected into
the marginal region with b-galactosidase mRNA as a tracer. After red-gal staining, whole-mount in situ hybridization for SoxD, XSIP1, and Zic3
was performed. The percentage of embryos showing decreased expression and the total number of examined embryos are indicated in each
figure. Figures for XSIP1 and Zic3 show the dorsal view.The present study also found that Dullard functions as
a phosphatase. As the substrates of the phosphatase,
we identified BMP type I receptors. As shown in Figures
3J–3M, Dullard suppressed BMP-dependent phosphor-
ylation of ALK3 by dephosphorylation. An intriguing find-
ing is that the phosphatase activity of Dullard is also cru-
cial for the degradation of BMPRII. Although we still do
not know the mechanisms, it is plausible that Dullard
may also recognize other unidentified substrates that
regulate the ubiquitination and degradation of BMPRII.
One possible explanation could be that Dullard may en-
hance the activity of the unidentified ubiquitin ligases by
dephosphorylation of the ligases. This process could
change interacting partners and modulate the ligase ac-
tivity as described previously (Ichimura et al., 2005; Yang
et al., 2006). Alternatively, Dullard inhibits BMP signaling
by converting the constitutively phosphorylated BMPRII
to a suitable dephosphorylated substrate for unknown
ubiquitin ligases. There are several reports that describe
specific degradation of unphosphorylated proteins by
ubiquitin-dependent mechanisms (Tanaka et al., 2005;
Katagiri et al., 2005; Coronella-Wood et al., 2004; Agar-
wal et al., 2003; Sato et al., 2003). To gain insight for
the ubiquitin ligases involved in Dullard-dependent
degradation of BMPRII, we tested a Smurf1-dependent
mechanism. However, overexpression of a ligase-
inactive mutant, Smurf1 (C710A), had no effect on the
Dullard-dependent degradation of BMPRII. Moreover,
coexpression of wild-type Smurf1 rather inhibited the
Dullard-dependent degradation of the receptor (data
not shown), suggesting that Dullard promotes the deg-
radation of BMPRII in a Smurf1-independent manner.
We speculate that Dullard functions as the phosphatase
for BMPRIs and unknown components of the BMPR
complexes to promote their dephosphorylation and
subsequent signaling pathways such as ubiquitin-de-
pendent degradation of the BMPRII.We previously identified dullard as an essential gene
for neural development (Satow et al., 2002). Here, phos-
phatase-inactive mutants, D67E and D69E, failed to pro-
mote degradation of BMPRII and acted as dominant-
negative forms of Dullard. Dullard inhibition by these
mutants or by Dullard-Mo upregulated the expression
of BMP target genes and suppressed the expression
of early neural genes. These results provide strong evi-
dence that Dullard functions as a negative regulator of
BMP signaling in vivo during Xenopus development.
Since dullard transcripts are maternally derived and
are expressed throughout early embryogenesis until
neurula stages (Satow et al., 2002), it is likely that Dullard
acts by repressing the occasional phosphorylation of
BMP type I receptors to bring about a very low level of
activity of these receptors or to temporarily limit the
signal duration, rather than to actively suppress BMP
signaling in the early developmental stages. Alterna-
tively, the activity of Dullard might be regulated by un-
known posttranscriptional or posttranslational mecha-
nisms to activate specifically in presumptive neural
regions. In later stages, dullard expression is restricted
to brain, eyes, neural region, branchial arches, and the
pronephros (Satow et al., 2002). The expression pattern
of dullard overlaps significantly with the expression pat-
tern of BMPRI (ALK3) and partially overlaps with that of
BMPRII (Shi et al., 2000; Frisch and Wright, 1998; Graff
et al., 1994), suggesting that Dullard may also regulate
BMP signaling in these regions late in development.
Very recently, one of the small C-terminal domain
phosphatase family members, SCP2/Os4, was identified
as a modulator of BMP-Smad phosphorylation (Knock-
aert et al., 2006). SCP2/Os4 is distantly related to Dullard,
but it is exclusively localized in the nucleus. Dullard likely
functions as a phosphatase for BMPRI in the cytoplasm,
but not for BMP-Smads in the nucleus, since Dullard is
only detected in the cytosol. Moreover, as shown in
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phosphorylation of Smad1/5/8 induced by caALK3.
These results suggest that Dullard does not directly de-
phosphorylate Smad proteins. However, it is very inter-
esting that similar phosphatases regulate the different
signaling molecules of BMP signaling in the cytoplasm
and nucleus. As these phosphorylation sites, the pSer-
X-pSer motifs of both the GS domain of type I receptors
and the C-terminal tail of Smads, show similarity and are
both recognized by the same pSer binding motif, the
Smad MH2 domain (Qin et al., 2001; Wu et al., 2001),
the similar phosphatases could be responsible for the
dephosphorylation of these motifs.
Experimental Procedures
Plasmid Construction
The catalytic domain mutants of dullard, D67E and D69E, were con-
structed by PCR amplification of pCS2-Dullard by using the T7
primer as the reverse primer and the following forward primers: 50-
CTAGTTCTAGAATTAGATGAGACCC-30, for D67E, and 50-CTAGTT
CTAGATTTAGAAGAGACCC-30, for D69E. The underlined sequence
indicates the internal XbaI sites. The amplified products were di-
gested with XbaI and cloned into the equivalent site in pCS2-Dullard.
To construct myc-Dullard, myc-D67E, and myc-D69E, the ORF se-
quences of dullard, D67E, and D69E, respectively, were amplified
by PCR and were then cloned into the StuI site of the pCS2-myc
plasmid. pNRRX-XSmad7 was constructed by using the full-length
cDNA clone of Smad7 obtained by our screening (Tanegashima
et al., 2000). To construct pCS2-XBMPRII-HA and pCS2-ActRII-
HA, the ORF sequence of XBMPRII (Frisch and Wright, 1998) and
ActRII (AR1) (Hemmati-Brivanlou et al., 1992), respectively, was in-
serted into pCS2-HA. The constitutively active form of ALK3
(pCS2-caALK3-HA) was constructed by inserting the ORF sequence
of caALK3 and the HA tag sequence into pCS2. The wild-type of
ALK3 plasmid, pCS2-ALK3-HA, was constructed by PCR-mediated
modification of pCS2-caALK3-HA. The mammalian expression plas-
mids for wild-type and mutated Dullard were generated by PCR
amplification of pCS2-myc-Dullard and were subcloned into the
pcDNA3-Flag vector.
Embryos and Microinjection
Preparation ofXenopus laevis embryos and microinjection were per-
formed as described previously (Satow et al., 2004). Staging of em-
bryos was performed according to Niewkoop and Faber (1994).
Capped mRNA was synthesized by in vitro transcription (mMES-
SAGE mMACHINE kit; Ambion). Plasmids encoding BMP4 (Nishi-
matsu et al., 1992), Xnr5 (Onuma et al., 2005), dullard (Satow et al.,
2002), D67E, D69E, caALK3-HA, XBMPPRII-HA, ALK3-HA, ALK3-
myc, and ActRII-HA were linearized with NotI and transcribed from
the SP6 promoter. XSmad7 was cut with SrfI and transcribed from
the T7 promoter. BMP4-HA (Haramoto et al., 2004) was cut with
Asp718 and transcribed from the SP6 promoter. In animal cap as-
says, mRNA was injected into the animal pole region of four-cell-
stage embryos. Animal caps were dissected at stages 8.5–9 and
were incubated in Steinberg’s solution containing 0.1% BSA until
harvesting.
RT-PCR
Total RNA isolation and RT-PCR were performed as described pre-
viously (Tanegashima et al., 2000). The primer pairs for XSIP1 (Nitta
et al., 2004), Msx1 (Yamamoto et al., 2000), Bambi (Onichtchouk
et al., 1999), and ODC (Chan et al., 2000) were described previously.
The primer sequences of Xvent-1 were: forward, 50-AAGTATGC
CAAGGAGATGCC-30; reverse, 50-AGCTTCTTCCGTTCAGATGC-30.
The primer pairs for Zic3 and Xbrawere as described in the Xenopus
Molecular Marker Resource web site (http://www.cbrmed.ucalgary.
ca/pvize/htm/WWW/Welcome.html). ODC and EF1a were used as
loading controls. ODC and EF1a primers were also used in reverse
transcriptase negative (RT2) reactions to confirm the absence of
contaminating genomic DNA.Antisense Morpholino Oligonucleotides
The antisense morpholino oligonucleotide for dullard (Dullard-Mo)
was described previously (Satow et al., 2002). The second antisense
morpholino oligonucleotide for dullard (Dullard-Mo2) was designed
to target 50-CGGTTACACTCCCATTCTGCTCTGG-30, which is lo-
cated in the 50 UTR region of dullard. A GenBank search for the com-
plement of the Dullard-Mo and Dullard-Mo2 sequences confirmed
the absence of a significant homology sequence in Xenopus. A con-
trol Mo was provided by Gene Tools. 5mis-Mo carrying five mismatch
nucleotides within the Dullard-Mo target sequence, 50-CGAGGT
GCCGTGGACTCCGCTTCAA-30, was also used as a control.
Immunoprecipitation and Immunoblotting
Xenopus embryos, dissected animal caps, or cultured mammalian
cells were lysed with a lysis buffer (1% Triton X-100, 250 mM NaCl,
50 mM HEPES [pH 7.0]) containing a protease inhibitor cocktail
(Roche) and a phosphatase inhibitor cocktail (Sigma) and were
then centrifuged. Anti-phospho-Smad1/5/8 (Cell Signaling) was
used to detect the C-terminally phosphorylated form of Smad1/5/
8. Antibodies against Smad1/5/8, Smad1, Smad2, ALK3, caveolin-
1, GFP, HA (Y11), and myc (9E10) were purchased from Santa
Cruz. Antibodies against actin, a-tubulin, diphosphorylated-
ERK1&2 (dp-MAPK), and Flag (M2) were purchased from Sigma.
HA antibodies, 12CA5 and 3F10, were purchased from Roche. Other
antibodies, including phospho-Smad2, BMPRII, and EEA1, were ob-
tained from Cell Signaling, R&D, and BD, respectively. Anti-rabbit
IgG-HRP (Sigma), anti-goat IgG-HRP (Sigma), and anti-mouse IgG-
HRP (Cell Signaling) were used as secondary antibodies. Immuno-
blot was obtained with a LAS-1000pro image analyzer (Fuji Film),
and the relative intensities of protein bands were quantitated with
Image Gauge software (Fuji Film).
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
Supplemental References, and five figures and are available at http://
www.developmentalcell.com/cgi/content/full/11/6/763/DC1/.
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